Ciclosporin (Sublimity)

N/A

Report date: 2026/01/21 17:01:00

Base Information

Drug NameCiclosporin (Sublimity)
Drug Alias NameCyclosporin - Sublimity TherapeuticsCyclosporine A - Sublimity TherapeuticsCyColCyLowCyCron +[10] 
ClassificationSmall molecules > Molecular Glue
Mechanisms of ActionCalcineurin inhibitorsImmunosuppressantsP-glycoprotein 1 inhibitors +[4] 
TargetsCalcineurinP-glycoprotein 1Mitochondrial permeability transition pore
Therapy Area/IndicationsRejection of organ transplantationGraft vs Host DiseasePsoriasis +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesSublimity Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesDr. Falk Pharma GmbH
Inactive CompaniesN/A
Active IndicationsRejection of organ transplantationGraft vs Host DiseasePsoriasis +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A